Population pharmacokinetics of amodiaquine and piperaquine in African pregnant women with uncomplicated Plasmodium falciparum infections

Abstract Artemisinin‐based combination therapy (ACT) is the first‐line recommended treatment for uncomplicated malaria. Pharmacokinetic (PK) properties in pregnant women are often based on small studies and need to be confirmed and validated in larger pregnant patient populations. This study aimed t...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	CPT: Pharmacometrics & Systems Pharmacology
المؤلفون الرئيسيون:	Junjie Ding, Richard M. Hoglund, Harry Tagbor, Halidou Tinto, Innocent Valéa, Victor Mwapasa, Linda Kalilani‐Phiri, Jean‐Pierre Van Geertruyden, Michael Nambozi, Modest Mulenga, Sebastian Hachizovu, Raffaella Ravinetto, Umberto D'Alessandro, Joel Tarning
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Wiley 2024-11-01
الوصول للمادة أونلاين:	https://doi.org/10.1002/psp4.13211

مواد مشابهة

Efficacy of artesunate–amodiaquine, dihydroartemisinin–piperaquine and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger
حسب: Francesco Grandesso, وآخرون
منشور في: (2018-01-01)

In vivo/ex vivo efficacy of artemether–lumefantrine and artesunate–amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso
حسب: Moussa Lingani, وآخرون
منشور في: (2020-01-01)

High cure rates and tolerability of artesunate–amodiaquine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Kibaha and Kigoma, Tanzania
حسب: Celine I. Mandara, وآخرون
منشور في: (2019-03-01)

Artemisinin-based combination therapy during pregnancy: outcome of pregnancy and infant mortality: a cohort study
حسب: Michael Nambozi, وآخرون
منشور في: (2019-03-01)

Efficacy of artemether-lumefantrine, artesunate-amodiaquine, dihydroartemisinin-piperaquine and artesunate-pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in Mozambique, 2022
حسب: Abel Nhama, وآخرون
منشور في: (2025-07-01)

The efficacy and tolerability of artemisinin-piperaquine (Artequick®) versus artesunate-amodiaquine (Coarsucam™) for the treatment of uncomplicated <it>Plasmodium falciparum</it> malaria in south-central Vietnam
حسب: Thanh Nguyen, وآخرون
منشور في: (2012-06-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
حسب: Hoglund Richard M, وآخرون
منشور في: (2012-11-01)

Efficacy of artesunate–amodiaquine in the treatment of falciparum uncomplicated malaria in Madagascar
حسب: Oméga Raobela, وآخرون
منشور في: (2018-08-01)

Efficacy and safety of dihydroartemisinin–piperaquine for treatment of Plasmodium falciparum uncomplicated malaria in adult patients on antiretroviral therapy in Malawi and Mozambique: an open label non-randomized interventional trial
حسب: Esperança Sevene, وآخرون
منشور في: (2019-08-01)

Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis.
حسب: Karol Marwa, وآخرون
منشور في: (2022-01-01)

Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
حسب: Ashenafi Assefa, وآخرون
منشور في: (2022-12-01)

Efficacy of artesunate-amodiaquine for treatment of uncomplicated Plasmodium falciparum malaria in mainland Tanzania
حسب: Billy Ngasala, وآخرون
منشور في: (2024-03-01)

Artesunate-amodiaquine efficacy in Congolese children with acute uncomplicated falciparum malaria in Brazzaville
حسب: Ndounga Mathieu, وآخرون
منشور في: (2013-02-01)

Correction: Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia
حسب: Ashenaf Assefa, وآخرون
منشور في: (2023-04-01)

Gametocytaemia in senegalese children with uncomplicated Falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine + pyrimethamine
حسب: Sokhina C.S, وآخرون
منشور في: (2001-09-01)

A randomised controlled trial to assess the efficacy of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Peru.
حسب: Tanilu Grande, وآخرون
منشور في: (2007-10-01)

Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
حسب: Basco Leonardo K., وآخرون
منشور في: (2002-01-01)

The impact of intermittent preventive treatment in school aged children with dihydroartemisinin piperaquine and artesunate amodiaquine on IgG response against six blood stage Plasmodium falciparum antigens.
حسب: Eric Lyimo, وآخرون
منشور في: (2025-01-01)

The assessment of gestational age: a comparison of different methods from a malaria pregnancy cohort in sub-Saharan Africa
حسب: Holger Unger, وآخرون
منشور في: (2019-01-01)

Therapeutic efficacy of artesunate–amodiaquine and artemether–lumefantrine for the treatment of uncomplicated falciparum malaria in Chad: clinical and genetic surveillance
حسب: Mahamat Souleymane Issa, وآخرون
منشور في: (2023-08-01)

Treatment Failure of Dihydroartemisinin/Piperaquine for Plasmodium falciparum Malaria, Vietnam
حسب: Bui Quang Phuc, وآخرون
منشور في: (2017-04-01)

A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali
حسب: Souleymane Dama, وآخرون
منشور في: (2018-10-01)

High efficacy of artemether–lumefantrine and dihydroartemisinin–piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania
حسب: Celine I. Mandara, وآخرون
منشور في: (2018-07-01)

Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria in Liberia, 2022–2023
حسب: Victor S. Koko, وآخرون
منشور في: (2025-10-01)

The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated <it>Plasmodium falciparum</it>
حسب: Kiechel Jean, وآخرون
منشور في: (2009-03-01)

Uncomplicated Clinical Malaria Features, the Efficacy of Artesunate-Amodiaquine and Their Relation with Multiplicity of Infection in the Democratic Republic of Congo.
حسب: Hypolite Muhindo Mavoko, وآخرون
منشور في: (2016-01-01)

Fetal biometry assessment with Intergrowth 21st’s and Salomon’s equations in rural Burkina Faso
حسب: Biébo Bihoun, وآخرون
منشور في: (2020-08-01)

Efficacy of quinine, artemether-lumefantrine and dihydroartemisinin-piperaquine as rescue treatment for uncomplicated malaria in Ugandan children.
حسب: Adoke Yeka, وآخرون
منشور في: (2013-01-01)

The plasmepsin-piperaquine paradox persists in Plasmodium falciparum.
حسب: Breanna Walsh, وآخرون
منشور في: (2025-07-01)

Efficacy of Artesunate + Sulphadoxine-Pyrimethamine (AS + SP) and Amodiaquine + Sulphadoxine-Pyrimethamine (AQ + SP) for Uncomplicated falciparum Malaria in Equatorial Guinea (Central Africa)
حسب: Pilar Charle, وآخرون
منشور في: (2009-01-01)

Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso.
حسب: Augustin Zoungrana, وآخرون
منشور في: (2008-02-01)

Evaluation of Dihydroartemisinin–Piperaquine Efficacy and Molecular Markers in Uncomplicated Falciparum Patients: A Study across Binh Phuoc and Dak Nong, Vietnam
حسب: Thu Huyen Thi Tran, وآخرون
منشور في: (2024-06-01)

Population Pharmacokinetic Properties of Piperaquine in Falciparum Malaria: An Individual Participant Data Meta-Analysis.
حسب: Richard M Hoglund, وآخرون
منشور في: (2017-01-01)

Therapeutic efficacy of dihydroartemisinin-piperaquine combination for the treatment of uncomplicated malaria in Ghana
حسب: Benjamin Abuaku, وآخرون
منشور في: (2023-01-01)

Therapeutic efficacy and safety of artesunate + amodiaquine and artemether + lumefantrine in treating uncomplicated Plasmodium falciparum malaria in children on the rainy south-east coast of Madagascar
حسب: Irinantenaina Judickaëlle, وآخرون
منشور في: (2023-01-01)

Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated <it>Plasmodium falciparum </it>malaria
حسب: Diallo Mouctar, وآخرون
منشور في: (2009-06-01)

A randomized trial on effectiveness of artemether-lumefantrine <it>versus </it>artesunate plus amodiaquine for unsupervised treatment of uncomplicated <it>Plasmodium falciparum </it>malaria in Ghanaian children
حسب: Hogan Benedikt, وآخرون
منشور في: (2008-12-01)

Evolution of genetic markers for drug resistance after the introduction of dihydroartemisinin–piperaquine as first-line anti-malarial treatment for uncomplicated falciparum malaria in Indonesia
حسب: Farindira Vesti Rahmasari, وآخرون
منشور في: (2023-08-01)

A randomised, double-blind clinical phase II trial of the efficacy, safety, tolerability and pharmacokinetics of a single dose combination treatment with artefenomel and piperaquine in adults and children with uncomplicated Plasmodium falciparum malaria
حسب: Fiona Macintyre, وآخرون
منشور في: (2017-10-01)

Amodiaquine failure associated with erythrocytic glutathione in <it>Plasmodium falciparum </it>malaria
حسب: Blair Silvia, وآخرون
منشور في: (2007-04-01)